Anodyne® Therapy announces the publication of its second peer-reviewed clinical study to demonstrate restoration of sensation in the feet of diabetic patients with peripheral neuropathy. This landmark study, conducted at the Joslin Diabetes Center at Morton Plant Hospital in Clearwater, Florida, appeared in the January 2004 issue of Diabetes Care (the Professional Journal of the American Diabetes Association) and is titled, “Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects with Diabetic Peripheral Neuropathy; A Randomized, Double Blind, Placebo Controlled Study.” The study showed that after 12 45-minute treatments, there was a 46 percent improvement in sensation, and pain decreased by 45 percent. Additionally, 70 percent of patients reported an improvement in balance and less fear of falling.
       Neuropathy is nerve damage often associated with diabetes and other chronic diseases. Symptoms include numbness and/or pain in the feet, legs, and hands. Neuropathy from some causes like diabetes is usually considered to be progressive and irreversible and is a major contributing factor to chronic foot wounds, over 60,000 amputations per year, and falls. The cost of diabetic neuropathy alone to the US healthcare system has been reported to exceed $37 billion per year.
       For more information, visit http://www.anodynetherapy.com.